During the previous studies, researches about PTP1B mainly focused on diabetes mellitus, because PTP1B is a negative insulin signaling pathway regulator; hence inhibiting PTP1B increases insulin sensitivity and effectively controls diabetes [20]. Here, INS is linked to diabetes mellitus.